Haleon Plc (HLNCF)
5.07
-0.12
(-2.31%)
USD |
OTCM |
Aug 25, 16:00
Haleon 1 Year Total Returns (Daily) : 6.31% for Aug. 25, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 25, 2026 | 6.31% |
| August 24, 2026 | 7.72% |
| August 21, 2026 | 0.13% |
| August 20, 2026 | 0.45% |
| August 19, 2026 | 4.94% |
| August 18, 2026 | 4.50% |
| August 17, 2026 | 3.28% |
| August 14, 2026 | 8.98% |
| August 13, 2026 | 1.16% |
| August 12, 2026 | 0.21% |
| August 11, 2026 | 4.45% |
| August 10, 2026 | 4.11% |
| August 07, 2026 | 7.18% |
| August 06, 2026 | 10.16% |
| August 05, 2026 | 8.33% |
| August 04, 2026 | 3.25% |
| August 03, 2026 | 7.42% |
| July 31, 2026 | 1.35% |
| July 30, 2026 | 2.59% |
| July 29, 2026 | 2.18% |
| July 28, 2026 | 2.50% |
| July 27, 2026 | 3.64% |
| July 24, 2026 | 0.53% |
| July 23, 2026 | 3.65% |
| July 22, 2026 | 4.84% |
| Date | Value |
|---|---|
| July 21, 2026 | 4.30% |
| July 20, 2026 | 3.60% |
| July 17, 2026 | 7.10% |
| July 16, 2026 | 4.42% |
| July 15, 2026 | -1.07% |
| July 14, 2026 | -0.70% |
| July 13, 2026 | -0.78% |
| July 10, 2026 | -2.37% |
| July 09, 2026 | -3.00% |
| July 08, 2026 | -1.86% |
| July 07, 2026 | -2.35% |
| July 06, 2026 | -0.19% |
| July 02, 2026 | -6.02% |
| July 01, 2026 | -10.15% |
| June 30, 2026 | -8.91% |
| June 29, 2026 | -8.25% |
| June 26, 2026 | -8.95% |
| June 25, 2026 | -10.94% |
| June 24, 2026 | -9.44% |
| June 23, 2026 | -12.97% |
| June 22, 2026 | -15.37% |
| June 18, 2026 | -12.05% |
| June 17, 2026 | -18.68% |
| June 16, 2026 | -19.58% |
| June 15, 2026 | -13.53% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| AstraZeneca PLC | 8.33% |
| GSK Plc | 36.12% |
| Hikma Pharmaceuticals Plc | -4.97% |
| Allergy Therapeutics Plc | 76.47% |
| Shield Therapeutics Plc | -36.23% |